MBIO - mustangbio.com Net Sales Margin

MBIO (Mustang Bio) - company brandmark

Mustang Bio, Inc. (MBIO) attracts investors with a scalable gene therapy platform that promises a high premium for intellectual property. The current net profit margin illustrates this trend, where the 0.00 level captures recent values. While partnerships with oncology centers and patent acquisitions bolster its potential, liquidity shortages and R&D expenses are forcing the company to divest assets for survival.

mustangbio.com (MBIO) Net Return on Sales: for the period 07/04/2022 - 11/20/2026

Summary analytical data breakdowns for Mustang Bio (MBIO)

- share price and consensus valuation forecast:
Basic company analysis:Mustang Bio, Inc. - MBIO
Finished products of mustangbio.com

Sales margin measures the share of net profit in every dollar of revenue, reflecting the ultimate efficiency of cost management. This metric allows an investor to assess a business's ability to convert revenue into real capital. By analyzing net profit margins on the GURU.Markets platform, one can identify cycles of operational stability. For Mustang Bio, Inc. (MBIO), this indicator depends directly on the volume of partner payments for CAR-T research.

Direct competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX